FoxP3 and Gata3 expressions were more accurate at reflecting progression rates than the time from first symptom to first exam, a currently used prognostic indicator of future ALS progression rates (Czaplinski et al, 2006; Kollewe et al, 2008). The gene discussed is GATA3; the disease is amyotrophic lateral sclerosis.